Firms Stop Cough/Cold Product Promotions For Use By Infants – CHPA
This article was originally published in The Tan Sheet
Consumer Healthcare Products Association member companies are no longer advertising or promoting their cough/cold products for use by children under the age of 2, CHPA says
You may also be interested in...
As FDA embarks on a lengthy rulemaking process to address pediatric OTC cough/cold products, the agency has strategies outside the regulatory framework available to effect any more immediate changes it deems necessary
An industry education campaign on proper use of cough/cold products in children will target decision-making points in consumers' lives, with a particular focus on reaching new mothers
Wyeth Consumer Healthcare is re-labeling its OTC pediatric cough/cold medicines to advise caregivers to consult physicians before administering the products to 2- to 6-year-old children, the firm says in comments submitted to FDA Oct. 3